Prescription medication · Inhaled Corticosteroid
mometasone
Also sold as Asmanex. This cream treats skin problems that cause inflammation and itching.
Data updated 2026-05-15
- 17,186
- FDA reportsModerately reported
- 3
- InteractionsFew interactions
- $0.28
- Generic price (NADAC)
What the data shows
mometasone (Asmanex) is a prescription Inhaled Corticosteroid, reported at a middle-of-the-pack volume (17,186 FDA reports), with 3 documented drug interactions.
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
mometasone (Asmanex) is a prescription Inhaled Corticosteroid. This cream treats skin problems that cause inflammation and itching.
Mometasone cream is a medicine that reduces skin inflammation and itching. It belongs to a class of drugs called corticosteroids.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Generic Price
$0.28/unit
Generic Available
Yes (16 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
NADAC price trail: MOMETASONE FUROATE 0.1% CREAM
Same CMS presentation as the headline generic unit price above (5 effective dates). Adjacent % compares consecutive NADAC releases for this description only, not a patient out-of-pocket quote. Latest step: +16.2% vs prior release.
| Effective | NADAC / unit | vs prior | NDCs |
|---|---|---|---|
| January 17, 2024 | $0.3308/GM | - | 1 |
| June 19, 2024 | $0.4576/GM | +38.3% | 1 |
| July 17, 2024 | $0.3964/GM | -13.4% | 1 |
| August 21, 2024 | $0.2959/GM | -25.4% | 1 |
| December 18, 2024 | $0.3438/GM | +16.2% | 4 |
What it does
This cream treats skin problems that cause inflammation and itching.
Common side effects
Burning, Itching, Skin thinning
Key warnings
Using too much mometasone cream, using it for a long time, or covering large areas of skin can increase the risk of side effects.
The sections below are summarized in plain English from mometasone's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Mometasone is a corticosteroid that reduces inflammation. It works by reducing the chemicals in the body that cause swelling and itching. This helps to relieve skin irritation.
Side Effects (from patient reports)
Based on 17,186 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for mometasone, by number of reports
- Dyspnoea
Dyspnoea
1,730 reports
- Asthma
Asthma
1,553 reports
- Headache
Headache
1,393 reports
- Cough
Cough
1,178 reports
- Fatigue
Fatigue
1,098 reports
- Wheezing
Wheezing
966 reports
- Gastrooesophageal Reflux Disease
Gastrooesophageal Reflux Disease
965 reports
- Pruritus
Pruritus
905 reports
- Nausea
Nausea
892 reports
- Pain
Pain
818 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for mometasone each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where mometasone sits
mometasone has more FDA adverse-event reports than 51% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is mometasone; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 17,186 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.
Total Reports
17,186
Reports Mentioning Death
814
4.7% of reports — not proof of cause
Hospitalization Reports
5,350
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 1 | DYSPNOEA | 1,730 |
| 2 | ASTHMA | 1,553 |
| 4 | HEADACHE | 1,393 |
| 5 | COUGH | 1,178 |
| 6 | FATIGUE | 1,098 |
| 8 | WHEEZING | 966 |
| 9 | GASTROOESOPHAGEAL REFLUX DISEASE | 965 |
| 10 | PRURITUS | 905 |
| 11 | NAUSEA | 892 |
| 12 | PAIN | 818 |
| 13 | PNEUMONIA | 804 |
| 14 | RASH | 761 |
| 15 | THERAPEUTIC PRODUCT EFFECT INCOMPLETE | 740 |
| 16 | DIARRHOEA | 720 |
| 17 | DIZZINESS | 685 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
Using too much mometasone cream, using it for a long time, or covering large areas of skin can increase the risk of side effects. This can cause your body to stop making enough of its own natural steroid hormones. Children are more likely to get these side effects. This medicine may also increase your risk of cataracts and glaucoma. Tell your doctor if you have blurred vision.
Known Drug Interactions
betamethasone budesonide ciclesonide fluticasone methylprednisolone mometasone triamcinolone ↑ corticosteroids Co-administration with corticosteroids (all routes of administration) of which exposures are significantly increased by strong CYP3A inhibitors can increase the risk for Cushing's syndrome and adrenal suppression.
Mechanism: Darunavir slows down how fast your body gets rid of mometasone, which can cause the steroid to reach dangerously high levels.
Corticosteroids primarily metabolized by CYP3A betamethasone, budesonide, ciclesonide, dexamethasone, fluticasone, methylprednisolone, mometasone, triamcinolone ↑ corticosteroid Co-administration with corticosteroids (all routes of administration) of which exposures are significantly increased by strong CYP3A inhibitors can increase the risk for Cushing’s syndrome and adrenal suppression.
Mechanism: Ritonavir stops your body from clearing out mometasone, which can lead to high steroid levels and cause serious hormonal imbalances.
7 DRUG INTERACTIONS No drug-drug interaction studies have been conducted with mometasone furoate cream.
Mechanism: There have been no specific studies done to see how these two forms of the same medicine interact with each other.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
What should I avoid while using mometasone cream?
Can I use bandages with this cream?
What if my skin gets irritated?
How long should I use this cream?
Can children use this cream?
What are the signs of skin thinning?
What should I do if I think I have side effects?
Can this cream interact with other medicines?
What does 'topical' mean?
What should I do if I accidentally swallow the cream?
What are the common side effects of mometasone?
Does mometasone interact with other medications?
What drug class is mometasone?
What pregnancy or breastfeeding source fields are listed for mometasone?
Related Medications in Inhaled Corticosteroid
Other drugs grouped near mometasone - same-class peers and common alternatives.
aclidinium
Tudorza Pressair
Compare with mometasone →
albuterol
Ventolin, ProAir
Albuterol is a drug that helps you breathe easier.
Compare with mometasone →
albuterol/ipratropium
Combivent Respimat, DuoNeb
Combivent Respimat is a combination medicine that helps open your airways.
Compare with mometasone →
beclomethasone
Qvar
Qvar Redihaler is an inhaled medicine that helps control asthma symptoms.
Compare with mometasone →
benralizumab
Fasenra
Fasenra is a medicine that can help treat severe asthma and EGPA.
Compare with mometasone →
Compare beyond drug class
Nationwide peers by FAERS volume & death-report share
Two PlainMeds-derived comparison paths for mometasone: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.
Similar FAERS report volume
Nearest drugs by total FAERS reports. This record: 17,186.
Similar death-report share
Nearest drugs by FAERS death-report share. This record: 4.74%.
- teriparatide Δ 0.01 pts · 111,257 reports · Parathyroid Hormone Analog 4.73%death share
- tofacitinib Δ 0.02 pts · 181,998 reports · JAK Inhibitor 4.76%death share
- timolol Δ 0.03 pts · 11,690 reports · Beta-Blocker (Ophthalmic) 4.70%death share
- fluocinonide Δ 0.07 pts · 5,460 reports · Topical Corticosteroid 4.67%death share
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on mometasone
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for mometasone
The FDA label for mometasone (sold under brand names such as Asmanex) classifies it as a prescription-only medication in the Inhaled Corticosteroid class. This cream treats skin problems that cause inflammation and itching. Official labeling lists 3 commonly reported side effects, including Burning, Itching, Skin thinning.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 17,186 voluntary reports. The database also lists 3 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS shows a generic unit cost of $0.28.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: July 9, 2019
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages